Back to Search
Start Over
Visualisation and quantification of subcutaneous injections of different volumes, viscosities and injection rates: An ex-vivo micro-CT study.
- Source :
-
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Dec; Vol. 113 (12), pp. 3447-3456. Date of Electronic Publication: 2024 Sep 19. - Publication Year :
- 2024
-
Abstract
- The effects of subcutaneous (SC) injection parameters such as drug formulation volume, viscosity and injection rate on therapeutic performance and tolerability have not been established for any drug product. In this study four groups of SC injections were performed on fresh ex vivo minipig abdominal tissue samples, varying volume (0.5-1 mL), viscosity (1-11 cP) and rate (0.02-0.1 mL/s). Micro-CT provided high resolution (50 micron) imaging of the SC tissues before and after injection, enabling a detailed 3D visualisation and analysis of how both injection parameters and tissue microstructure influence spatial distribution of injectables. We found that volume was the only significant factor for spatial distribution of injectate within our design space, and there were no significant factors for tissue backpressure. Variability within test groups was typically greater than differences between group means. Accordingly, whilst the higher viscosity formulations consistently exhibited reduced spatial distribution, the sample size was not large enough to establish confidence in this result. Comparing our findings to clinical evidence, we conclude that injection site and depth are more likely to influence PK and bioavailability than volume, viscosity and rate within our experimental space.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Novartis sponsored and funded the study; contributed to the design; participated in interpretation of data; and in writing, reviewing, and approval of the final version. G.B., M.P., K. B-P., and T.D. are full-time employees of Novartis and shareholders of Novartis.<br /> (Copyright © 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1520-6017
- Volume :
- 113
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Journal of pharmaceutical sciences
- Publication Type :
- Academic Journal
- Accession number :
- 39306036
- Full Text :
- https://doi.org/10.1016/j.xphs.2024.08.019